stockrow
Friday 6 November 2026
Export VREX’s income statement to Excel — free account
VAREX IMAGING
VREX Healthcare Medical Devices
VAREX IMAGING’s revenue for fiscal 2025 (year ended September 2025) was $844.6 million, up 4.14% from fiscal 2024.
- Revenue
- +3.69%
- EPS
- +117.2%
- Free cash flow
- +757.1%
- Total debt
- −5.55%
Quarter to June 2026, against a year earlier
18.44
0.00
0.00%
Follow VREX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 3 | 5 | 6 |
+8 more TTM periods Free account |
| 4.51% | (15.72%) | (12.96%) | (13.65%) | ||
| 2.03% | (6.76%) | (5.57%) | (6.06%) | ||
ROIC |
5.95% | (2.62%) | (2.01%) | (2.49%) | |
Return on Tangible Assets |
3.59% | (13.93%) | (10.73%) | (11.48%) | |
Average Days of Receivables |
61.06 | 63.04 | 62.58 | 67.68 | |
Free Cash Flow per Share |
(0.48) | (0.73) | (0.32) | 0.45 | |
Free Cash Flow |
(20.20) | (30.80) | (13.30) | 18.80 | |
Capital Expenditures |
(31.50) | (28.80) | (29.40) | (22.90) | |
| Other line items | |||||
Cash ROIC |
(2.11%) | (3.33%) | (1.35%) | 1.86% | |
Accounts Receivable Turnover |
6.14 | 5.84 | 6.00 | 5.37 | |
Accounts Payable Turnover |
7.37 | 6.82 | 7.79 | 8.59 | |
Inventory Turnover |
1.76 | 1.80 | 1.85 | 1.96 | |
Average Days of Payables |
53.65 | 61.75 | 51.19 | 46.04 | |
Days of Inventory on Hand |
223.01 | 222.09 | 212.80 | 197.22 | |
Tax Rate |
(0.19) | 0.10 | 0.16 | 0.18 | |
Research and Development Expense of Revenue |
10.57% | 10.44% | 10.45% | 10.79% | |
Selling, General and Administrative Expense of Revenue |
15.41% | 15.81% | 15.47% | 15.78% | |
Share Based Compensation of Revenue |
1.73% | 1.74% | 1.72% | 1.78% | |
Interest Coverage |
1.86 | (0.74) | (0.67) | (0.78) | |
Operating CF/Net income |
0.51 | 0.02 | (0.24) | (0.59) | |
Depreciation/Fixed assets |
0.17 | 0.75 | 0.77 | 0.78 | |
Capex/Depreciation |
(1.09) | (0.23) | (0.24) | (0.18) | |
Revenue per Share |
20.55 | 20.42 | 20.44 | 20.40 | |
Operating CF per Share |
0.27 | (0.05) | 0.39 | 1.01 | |
Capex per Share |
(0.75) | (0.69) | (0.70) | (0.55) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 25 Oct 2026